VRNA Projected Dividend Yield
ADR (Sponsored)/Verona Pharma Plc (Adderbury) ( NASDAQ : VRNA )Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Co.'s product candidate, ensifentrine, is an inhaled, dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes. Co. is developing ensifentrine in three formulations for the inhalation devices: nebulizer, dry powder inhaler and pressurized metered-dose inhaler. 20 YEAR PERFORMANCE RESULTS |
VRNA Dividend History Detail VRNA Dividend News VRNA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |